Sunesis Pharmaceuticals (SNNS) Higher Following Publication of Positive Nonclinical Data
Tweet Send to a Friend
Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) is 18 percent higher in pre-open trading following the publication of new positive nonclinical studies ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
